selected publications
- Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 Therapy. Frontiers in genome editing. 2021 Review GET IT
-
Computational Design of gRNAs Targeting Genetic Variants Across HIV-1 Subtypes for CRISPR-Mediated Antiviral Therapy.
Frontiers in cellular and infection microbiology.
2021
Academic Article
GET IT
Times cited: 4 -
HIV-1 cure strategies: why CRISPR?.
Expert opinion on biological therapy.
2021
Review
GET IT
Times cited: 6 -
Designing Safer CRISPR/Cas9 Therapeutics for HIV: Defining Factors That Regulate and Technologies Used to Detect Off-Target Editing.
Frontiers in microbiology.
2020
Review
GET IT
Times cited: 10 -
Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding Sites.
Molecular therapy. Nucleic acids.
2020
Academic Article
GET IT
Times cited: 12 -
Novel gRNA design pipeline to develop broad-spectrum CRISPR/Cas9 gRNAs for safe targeting of the HIV-1 quasispecies in patients.
Scientific reports.
2019
Academic Article
GET IT
Times cited: 20 -
Computational Analysis Concerning the Impact of DNA Accessibility on CRISPR-Cas9 Cleavage Efficiency.
Molecular therapy : the journal of the American Society of Gene Therapy.
2019
Academic Article
GET IT
Times cited: 21 -
Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection.
Frontiers in microbiology.
2018
Review
GET IT
Times cited: 45